The National Institute of Health (NIH) Guidelines require that each institution
conducting or sponsoring recombinant DNA research is responsible for ensuring
that research is conducted in accordance with NIH Guidelines. In addition,
institutions must establish an Institutional Biosafety Committee (IBC) composed
of no fewer than five members collectively having experience and expertise
in recombinant DNA research.
North Dakota State University endorses this regulation and has an established
Institutional Biosafety Committee. The NDSU IBC's purpose is to assure the
safe use of recombinant DNA, infectious agents, and human blood, bodily fluids,
or tissues, in research and teaching, and to maintain compliance with NIH
Guidelines and additional federal regulations.
All project directors of research and teachers of courses involving recombinant
DNA, infectious agents, or human blood, bodily fluids or tissue at NDSU, or
conducted by representatives of NDSU, are responsible for submitting the protocol
forms required for review and approval by the NDSU Institutional Biosafety
Committee.
Further information about the IBC can be obtained from the Office of Sponsored
Programs Administration (Research 1, Rm 132, phone 701.231.8114, email: ndsu.ibc@ndsu.edu).
The NDSU Institutional Biosafety Committee is administered by the Office of
Sponsored Programs Administration (Division of the Vice President for Research,
Creative Activities and Technology Transfer).
HISTORY: July 31, 2001
Aubrey Ketterling
Last Updated: Tuesday, January 22, 2002, 2:31 PM
Published by North Dakota State University
